Outcomes of prophylactic cranial irradiation in patients with small cell lung cancer in the modern era of baseline magnetic resonance imaging of the brain

References

• Danckert BF, Engholm G, Hansen HL, et al. NORDCAN: cancer incidence, mortality, prevalence and survival in the Nordic countries, Version 8.2. 2019.
   Google Scholar
• Spiro SG, Porter JC. Lung cancer-where are we today? Current advances in staging and nonsurgical treatment. Am J Respir Crit Care Med. 2002;166(9):1166–1196.
   PubMed Web of Science ®Google Scholar
• van Meerbeeck JP, Fennell DA, De Ruysscher DK. Small-cell lung cancer. Lancet. 2011;378(9804):1741–1755.
   PubMed Web of Science ®Google Scholar
• Clouston PD, DeAngelis LM, Posner JB. The spectrum of neurological disease in patients with systemic cancer. Ann Neurol. 1992;31(3):268–273.
   PubMed Web of Science ®Google Scholar
• Nieder C, Haukland E, Mannsåker B, et al. Presence of brain metastases at initial diagnosis of cancer: patient characteristics and outcome. Cureus. 2019;11(2):e4113.
   PubMed Web of Science ®Google Scholar
• Hochstenbag MM, Twijnstra A, Wilmink JT, et al. Asymptomatic brain metastases (BM) in small cell lung cancer (SCLC): MR-imaging is useful at initial diagnosis. J Neurooncol. 2000;48(3):243–248.
   PubMed Web of Science ®Google Scholar
• Aupérin A, Arriagada R, Pignon JP, et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med. 1999;341(7):476–484.
   PubMed Web of Science ®Google Scholar
• ASTRO. [cited 2020 Dec 9]. Available from: https://www.practicalradonc.org/article/S1879-8500(20)30053-9/fulltext.
   Google Scholar
• ESTRO. [cited 2020 Dec 30]. Available from: https://www.estro.org/Science/Guidelines.
   Google Scholar
• Slotman BJ, Mauer ME, Bottomley A, et al. Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms: results of an international Phase III randomized controlled trial by the EORTC Radiation Oncology and Lung Cancer Groups. J Clin Oncol. 2009;27(1):78–84.
   PubMed Web of Science ®Google Scholar
• Takahashi T, Yamanaka T, Seto T, et al. Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2017;18(5):663–671.
   PubMed Web of Science ®Google Scholar
• Lee JS, Murphy WK, Glisson BS, et al. Primary chemotherapy of brain metastasis in small-cell lung cancer. J Clin Oncol. 1989;7(7):916–922.
   PubMed Web of Science ®Google Scholar
• Grønberg BH, Killingberg KT, Fløtten Ø, et al. High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial. Lancet Oncol. 2021;22(3):321–331.
   PubMed Web of Science ®Google Scholar
• Ozawa Y, Omae M, Fujii M, et al. Management of brain metastasis with magnetic resonance imaging and stereotactic irradiation attenuated benefits of prophylactic cranial irradiation in patients with limited-stage small cell lung cancer. BMC Cancer. 2015;15:589.
   PubMed Web of Science ®Google Scholar
• Mamesaya N, Wakuda K, Omae K, et al. Efficacy of prophylactic cranial irradiation in patients with limited-disease small-cell lung cancer who were confirmed to have no brain metastasis via magnetic resonance imaging after initial chemoradiotherapy. Oncotarget. 2018;9(25):17664–17674.
   PubMedGoogle Scholar
• Pezzi TA, Fang P, Gjyshi O, et al. Rates of overall survival and intracranial control in the magnetic resonance imaging era for patients with limited-stage small cell lung cancer with and without prophylactic cranial irradiation. JAMA Netw Open. 2020;3(4):e201929.
   PubMed Web of Science ®Google Scholar
• Ghanta S, Keller A, Rodriguez-Lopez JL, et al. Utility of prophylactic cranial irradiation for limited stage small cell lung cancer in the modern era with magnetic resonance imaging surveillance. Clin Oncol (R Coll Radiol). 2021;33(8):e323–e30.
   PubMed Web of Science ®Google Scholar
• Xu J, Yang H, Fu X, et al. Prophylactic cranial irradiation for patients with surgically resected small cell lung cancer. J Thorac Oncol. 2017;12(2):347–353.
   PubMed Web of Science ®Google Scholar
• Zhu H, Guo H, Shi F, et al. Prophylactic cranial irradiation improved the overall survival of patients with surgically resected small cell lung cancer, but not for stage I disease. Lung Cancer. 2014;86(3):334–338.
   PubMed Web of Science ®Google Scholar
• Moon HI, Nam JS, Leem MJ, et al. Periventricular white matter lesions as a prognostic factor of swallowing function in older patients with mild stroke. Dysphagia. 2017;32(4):480–486.
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov [Internet]. EORTC: National Library of Medicine (US). -. Identifier NCT04790253, PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients (PRIMALung Study) (PRIMALung); 2021. March 10 [cited 2021 Aug 13]. Available from: https://clinicaltrials.gov/ct2/show/NCT04790253?term=PCI%2C+EORTC&cond=SCLC&draw=2&rank=1.
   Google Scholar
• ClinicalTrials.gov [Internet]. C. Rusthoven: National Library of Medicine (US). -. Identifier NCT04155034, SWOG S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer; 2019 November 7th [cited 2021 Aug 13]. Available from: https://clinicaltrials.gov/ct2/show/NCT04155034?term=PCI+SWOG&cond=SCLC&draw=2&rank=1.
   Google Scholar